Spectrofluorimetric and spectrophotometric stability-indicating methods for determination of some oxicams using 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD-Cl)

Chemical and Pharmaceutical Bulletin

Volumn 54, Issue 5, 2006, Pages 653-658

  Taha, Elham Anwer ^a   Salama, Nahla Nour ^a   Fattah, Laila El Sayed Abdel ^b  

^a NATIONAL ORGANIZATION FOR DRUG CONTROL AND RESEARCH NODCAR   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

7 chloro 4 nitrobenz 2 oxa 1,3 diazole; Dosage form; Oxicam; Spectrofluorimetry; Spectrophotometry; Stability indicating assay

Indexed keywords

4 CHLORO 7 NITROBENZOFURAZAN; LORNOXICAM; MELOXICAM; OXICAM DERIVATIVE; TENOXICAM;

ARTICLE; SPECTROFLUOROMETRY; SPECTROPHOTOMETRY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BUFFERS; CAPSULES; DRUG STABILITY; HYDROGEN-ION CONCENTRATION; INDICATORS AND REAGENTS; NITROBENZENES; OXAZOLES; PHARMACEUTICAL SOLUTIONS; PIROXICAM; POWDERS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ULTRAVIOLET; TABLETS; THIAZINES; THIAZOLES;

EID: 33646389261     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.54.653     Document Type: Article

References (32)

1. "Merck Index", 13th ed., Merck and Co. Inc., Whitehouse Station, N. J., U.S.A., 2001, p. 1000.
2. British Pharmacopoeia, Her, Majestys Stationery Office, London, 2003, p. 1203, 1795, 2661, 2662.
3. Martindale, "The Extra Pharmacopoeia," 33rd ed., The Pharmaceutical Press, London, 2002, p. 50, 51, 87.
4. Gilman A. G., Limbird L. E., Hardman J. G., "The Pharmacological Basis of Therapeutics," 10th ed., Goodman and Gilman's, McGraw-Hill, New York, U.S.A., 2001, p. 731.
5. Pruss T. P., Stroissnig H., Radhofer-Welte S., Wendtlandt W., Mehdi N., Takacs F., Fellier H., Postgrad. Med. J., 66 (Suppl. 4), S18-S21 (1990).
6. Taha E. A., El-Zanfally E. S., Salama N. N., Sci. Pharm., 71, 303-320 (2003).
7. Ghoneim M. M., Beltagi A. M., Radi A., Anal. Sci., 18, 183-186 (2002).
8. Taha E. A., Salama N. N., Abdel Fattah L. S., AOAC Inter., 87, 366-376 (2004).
9. Joseph-Charles J., Bertucat M., J. Liq. Chromatogr. Relat. Technol., 22, 2009-2021 (1999).
10. Radhofer-Welte S., Dittrich P., J. Chromatogr. Biomed. Appl., 707, 151-159 (1998).
11. El-Ries M. A., Anal. Lett., 31, 793-807 (1998).
12. AL-Tamrah S. A., Anal. Chim. Acta, 375, 277-283 (1998).
13. Taha E. A., Salama N. N., Abdel Fattah L. S., Spectrosc. Lett., 35, 501-516 (2002).
14. Barary M. H. Abdel-Hay M. H., Sabry S. M., J. Pharm. Biomed. Anal., 34, 221-226 (2004).
15. Mohamed H. A., Wadood H. M. A., Farghaly O. A., J. Pharm. Biomed. Anal., 28, 819-826 (2002).
16. Atay O., Dincol F., Anal. Lett., 30, 1675-1684 (1997).
17. Atkopar Z., Tuncel M., Anal. Lett., 29, 2383-2397 (1996).
18. Ozaltin N., Anal. Chim. Acta, 406, 183-189 (2000).
19. Khalil S., Borham N., El-Ries M. A., Anal. Chim. Acta, 414, 215-219 (2000).
20. Mason J. L., Hobbs G. J., J. Chromatogr. Biomed. Appl., 665, 410-415 (1995).
21. Sane R. T., Surve V., Francis M., Indian Drugs, 37, 390-393 (2000).
22. Bebawy L. I., Spectrosc. Lett., 31, 797-820 (1998).
23. Joseph-Charles J., Bertucat M., Anal. Lett., 32, 2051-2059 (1999).
24. Hasan E. M., J. Pharm. Biomed. Anal., 27, 771-777 (2002).
25. Radi A., El-Ries M. A., El-Anwar F., El-Sherif Z., Anal. Lett., 34, 739-748 (2001).
26. Radi A., El-Ries M. A., El-Anwar F., El-Sherif Z., Beltagi A. M., Ghoneim M. M., J. Pharm. Biomed. Anal., 27, 795-801 (2002).
27. Ding L., Chen H., Jiang H., Hou Y. Y., Zhang Z. X., Zhongguo Yiyao Gongye Zazhi, 33, 131-133 (2002).
28. Baeyens W. R. G., Van der Weken G., D'haeninck E., Garcia-Campana A. M., Vankeirsbilck T., Vercauteren A., Deprez P., J. Pharm. Biomed. Anal., 32, 839-846 (2003).
29. Nevin O., Sidika E., Sedef A., J. Pharm. Biomed. Anal., 29, 1-5 (2002).
30. Francois V. H., Aubin H., Anal. Chem., 46, 286-288 (1974).
31. Taha E. A., Anal. Bioanal. Chem., 376, 1131-1136 (2003).
32. El-Emam A. A., Hansen S. H., Moustafa M. A., El-Ashry S. M., El-Sherbiny D. T., J. Biomed. Anal., 34, 35-44 (2004).